Rising Legal Star Emily Oldshue Shines in M&A Negotiations and Collaboration

The third installment of ALM’s inaugural New England Legal Awards, which recognizes exceptional attorneys from over 80 firms across the region, is currently underway in Boston. Among the notable attorneys gaining attention in these early stages of their careers is Emily Oldshue from Ropes & Gray.

Oldshue has made a distinguished name for herself in the field of legal practice, notably in the area of strategic acquisitions. Last year alone, she represented Pfizer in over $18 billion worth of such transactions. It was her negotiation prowess and strategic execution of complex transactions that enabled her to navigate and resolve wide-ranging issues at the inception of Pfizer’s $11.6 billion deal with Biohaven Pharmaceuticals.

This Ropes & Gray associate further demonstrated her expertise in the M&A arena through the implementation of a bespoke risk allocation around non-disclosed clinical trial data linked to Pfizer’s $6.7 billion deal with Arena Pharmaceuticals. Her innovative approach to royalty structuring aided in bridging a valuation gap in the company’s dealings with Biohaven Pharmaceuticals.

To tackle these complex deal negotiations, Oldshue brought together a team of over 100 attorneys from 10 different Ropes offices, further establishing her skill in leadership and collaboration within the field.

For more information about other distinguished attorneys coming to the fore, visit the original article of ALM’s series.